According to statistics available from the Mexican Association of Innovative Medical Device Industries (AMID), with exports of around MXN 7.699 billion annually, Mexico is currently the ninth largest exporter and first in Latin America. Based on the geographical advantages, trade agreements, attractiveness of the domestic market in the future and access opportunities for popular insurance, Mexico has the potential to become the exporting country number seven worldwide by the end of 2020, when domestic production of devices may reach a value of MXN 19 billion. Consulting firm KPMG’s data states that medical device manufacturing in Mexico, including healing materials to highly specialized equipment for detection of disease, is 18.9% cheaper than in the United States. The main destinations of Mexican exports are the United States, with a share of 92.2%; Ireland, with 2.2%; and France with 1.6%, which mainly require syringes, needles, catheters and bandages, representing 35.6% of all Mexican exports. The second most exported category corresponded to therapeutic applications and portable implants, with 9.4%; followed by the diagnostic imaging equipment, with 7.7%; prostheses and orthopedic, with 5.8%; and dental products, with 2.3%. The remaining 39.2% were exports of other devices.
Mexico may become the seventh largest world exporter of syringes, needles and catheters
GHI Analysis1 min read
GHI Analysis
The leading source of MedTech market intelligence in Latin America. Verified data and competitor insights across the key markets in the region. At GHI, we turn hospital data into strategic actions. Our insights help healthcare companies expand by providing accurate, up-to-date information on hospital infrastructure in LATAM and Asia.
Related Posts
News
Colombia to regularize prices of medical devices
Colombia to regularize prices of medical devices
Columbia’s Ministry of Health & Social Protection has announced new price regulations for medical devices…
GHI Analysismarço 4, 2015
News
Brazilian researchers: Bureaucracy responsible for limitations over clinical research
Brazilian researchers: Bureaucracy responsible for limitations over clinical research
According to an open letter written to President Dilma Rousseff by a group of 44…
GHI Analysisagosto 25, 2015
Análise de GHIAnálise de GHINão categorizado
Os hospitais mais bem equipados do Brasil em 2023
Os hospitais mais bem equipados do Brasil em 2023
Embora existam vários rankings de hospitais brasileiros, a maioria tem como objetivo eleger os “melhores”,…
Carolina Chazarojulho 12, 2023